|
Volumn 94, Issue 11, 2000, Pages 1123-1129
|
Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.
a b b c |
Author keywords
Chronic obstructive pulmonary disease; Cost; Cost analysis; Cost of illness; Medical resource utilization
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BRONCHODILATING AGENT;
OXYGEN;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COST BENEFIT ANALYSIS;
DIAGNOSTIC PROCEDURE;
DISEASE SEVERITY;
DRUG COST;
EMERGENCY TREATMENT;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HEALTH SURVEY;
HOSPICE;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MEDICAID;
MEDICARE;
NURSING HOME;
OUTPATIENT CARE;
OXYGEN THERAPY;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSPECTIVE PAYMENT;
REIMBURSEMENT;
RESOURCE ALLOCATION;
UNITED STATES;
|
EID: 0033646274
PISSN: 09546111
EISSN: None
Source Type: Journal
DOI: 10.1053/rmed.2000.0933 Document Type: Article |
Times cited : (70)
|
References (31)
|